Disordered vascular compliance in haemochromatosis

Irish Journal of Medical Science

Volumn 183, Issue 2, 2014, Pages 303-309

  Cash, W J ^a,b   O'Neill, S ^a   O'Donnell, M E ^a   McCance, D R ^a   Young, I S ^a   McEneny, J ^a   Cadden, I S ^a   McDougall, Neil I ^a   Callender, M E ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Antioxidant; Arterial; Compliance; Haemochromatosis; Iron; Vascular

Indexed keywords

ADULT; AGED; ASCORBIC ACID; BIOLOGICAL MARKERS; BLOOD PRESSURE; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; COMPLIANCE; ENDOTHELIUM, VASCULAR; FEMALE; GAMMA-TOCOPHEROL; HEMOCHROMATOSIS; HOMOZYGOTE; HUMANS; LIPID PEROXIDES; MALE; MIDDLE AGED; PULSE WAVE ANALYSIS; RISK FACTORS; SEX FACTORS; VITAMIN A;

EID: 84905197972     PISSN: 00211265     EISSN: 18634362     Source Type: Journal    
DOI: 10.1007/s11845-013-1010-2     Document Type: Article

References (46)

1. Sullivan JL (1981) Iron and the sex difference in heart disease risk. Lancet 1(8233):1293-1294
2. Salonen JT, Nyyssonen K, Korpela H, Tuomilehto J, Seppanen R, Salonen R (1992) High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 86(3):803-811
3. Salonen JT, Korpela H, Nyyssonen K et al (1995) Lowering of body iron stores by blood letting and oxidation resistance of serum lipoproteins: a randomized cross-over trial in male smokers. J Intern Med 237(2):161-168
4. Kiechl S, Willeit J, Egger G, Poewe W, Oberhollenzer F (1997) Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Circulation 96(10):3300-3307 (Pubitemid 27513398)
5. Tuomainen TP, Punnonen K, Nyyssonen K, Salonen JT (1998) Association between body iron stores and the risk of acute myocardial infarction in men. Circulation 97(15):1461-1466 (Pubitemid 28191301)
6. Tuomainen TP, Kontula K, Nyyssonen K, Lakka TA, Helio T, Salonen JT (1999) Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation: a prospective cohort study in men in eastern Finland. Circulation 100(12):1274-1279 (Pubitemid 29440118)
7. Brissot P, Deugnier Y, Le Treut A, Regnouard F, Simon M, Bourel M (1978) Ascorbic acid status in idiopathic hemochromatosis. Digestion 17(6):479-487 (Pubitemid 9024028)
8. Herbert V (1999) Hemochromatosis and vitamin C. Ann Intern Med 131(6):475-476
9. Brissot P, Le Treut A, Dien G, Cottencin M, Simon M, Bourel M (1978) Hypovitaminemia A in idiopathic hemochromatosis and hepatic cirrhosis. Role of retinol-binding protein and zinc. Digestion 17(6):469-478 (Pubitemid 9024027)
10. von Herbay A, de Groot H, Hegi U, Stremmel W, Strohmeyer G, Sies H (1994) Low vitamin E content in plasma of patients with alcoholic liver disease, hemochromatosis and Wilson's disease. J Hepatol 20(1):41-46 (Pubitemid 24043084)
11. Young IS, Trouton TG, Torney JJ, McMaster D, Callender ME, Trimble ER (1994) Antioxidant status and lipid peroxidation in hereditary haemochromatosis. Free Radic Biol Med 16(3):393-397 (Pubitemid 24122885)
12. Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352(16):1685-1695. doi:10.1056/NEJMra043430
13. Ross R (1999) Atherosclerosis - an inflammatory disease. N Engl J Med 340(2):115-126. doi:10.1056/nejm199901143400207
14. Stocker R, Keaney JF Jr (2004) Role of oxidative modifications in atherosclerosis. Physiol Rev 84(4):1381-1478. doi:10.1152/physrev.00047.2003 (Pubitemid 39302636)
15. Lekakis J, Papamicheal C, Stamatelopoulos K et al (1999) Hemochromatosis associated with endothelial dysfunction: evidence for the role of iron stores in early atherogenesis. Vasc Med 4(3):147-148 (Pubitemid 29426365)
16. Gaenzer H, Marschang P, Sturm W et al (2002) Association between increased iron stores and impaired endothelial function in patients with hereditary hemochromatosis. J Am Coll Cardiol 40(12):2189-2194 (Pubitemid 36005907)
17. Wilkinson IB, Hall IR, MacCallum H et al (2002) Pulse-wave analysis: clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol 22(1):147-152 (Pubitemid 34076246)
18. O'Rourke MF, Gallagher DE (1996) Pulse wave analysis. J Hypertens Suppl 14(5):S147-S157 (Pubitemid 27051090)
19. Cockcroft JR, Wilkinson IB (2002) Arterial stiffness and pulse contour analysis: an age old concept revisited. Clin Sci (Lond) 103(4):379-380. doi:10.1042/
20. Vuilleumier JP, Keller HE, Keck E (1990) Clinical chemical methods for the routine assessment of the vitamin status in human populations. Part III: the apoenzyme stimulation tests for vitamin B1, B2 and B6 adapted to the Cobas-Bio analyzer. Int J Vitam Nutr Res 60(2):126-135 (Pubitemid 20331872)
21. Craft NE WSA, Soares JH (1992) Optimization of an isocratic high-performance liquid chromatographic separation of carotenoids. J Chromatogr 589:171-176
22. Mattace-Raso FH, Hofman A, Verwoert GC et al (2010) Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'. Eur Heart J 31(19):2338-2350. doi:10.1093/eurheartj/ehq165
23. Sempos CT (2002) Do body iron stores increase the risk of developing coronary heart disease? Am J Clin Nutr 76(3):501-503
24. Sun Q, Ma J, Rifai N, Franco OH, Rexrode KM, Hu FB (2008) Excessive body iron stores are not associated with risk of coronary heart disease in women. J Nutr 138(12):2436-2441. doi:10.3945/jn.108.097766
25. Magnusson MK, Sigfusson N, Sigvaldason H, Johannesson GM, Magnusson S, Thorgeirsson G (1994) Low iron-binding capacity as a risk factor for myocardial infarction. Circulation 89(1):102-108 (Pubitemid 24026478)
26. van der AD, Rovers MM, Grobbee DE et al (2008) Mutations in the HFE gene and cardiovascular disease risk: an individual patient data meta-analysis of 53 880 subjects. Circ Cardiovasc Genet 1(1):43-50. doi:10.1161/circgenetics.108. 773176
27. Miller M, Hutchins GM (1994) Hemochromatosis, multiorgan hemosiderosis, and coronary artery disease. JAMA 272(3):231-233 (Pubitemid 24209086)
28. Valenti L, Swinkels DW, Burdick L et al (2011) Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 21(8):568-575. doi:10.1016/j.numecd.2010.01. 003
29. Wang L, Johnson EE, Shi HN, Walker WA, Wessling-Resnick M, Cherayil BJ (2008) Attenuated inflammatory responses in hemochromatosis reveal a role for iron in the regulation of macrophage cytokine translation. J Immunol 181(4):2723-2731
30. Sullivan JL (2009) Do hemochromatosis mutations protect against iron-mediated atherogenesis? Circ Cardiovasc Genet 2(6):652-657. doi:10.1161/circgenetics.109.906230
31. Blacher J, Asmar R, Djane S, London GM, Safar ME (1999) Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 33(5):1111-1117 (Pubitemid 29230958)
32. Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362(6423):801-809. doi:10.1038/362801a0
33. Celermajer DS, Sorensen KE, Gooch VM et al (1992) Noninvasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340(8828):1111-1115
34. Lum H, Roebuck KA (2001) Oxidant stress and endothelial cell dysfunction. Am J Physiol Cell Physiol 280(4):C719-C741
35. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL (1989) Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320(14):915-924. doi:10.1056/nejm198904063201407 (Pubitemid 19101597)
36. Bozzini C, Girelli D, Tinazzi E et al (2002) Biochemical and genetic markers of iron status and the risk of coronary artery disease: an angiography-based study. Clin Chem 48(4):622-628 (Pubitemid 34261225)
37. Lipinski B, Pretorius E, Oberholzer HM, van der Spuy WJ (2012) Interaction of fibrin with red blood cells: the role of iron. Ultrastruct Pathol 36(2):79-84. doi:10.3109/01913123.2011.627491
38. Lipinski B, Pretorius E (2012) Novel pathway of ironinduced blood coagulation: implications for diabetes mellitus and its complications. Pol Arch Med Wewn 122(3):115-122
39. Pretorius E, Lipinski B (2013) Differences in morphology of fibrin clots induced with thrombin and ferric ions and its pathophysiological consequences. Heart Lung Circ 22(6):447-449. doi:10.1016/j.hlc.2012.10.010
40. Pretorius E, Bester J, Vermeulen N, Lipinski B (2013) Oxidation inhibits iron-induced blood coagulation. Curr Drug Targets 14(1):13-19
41. Lipinski B, Pretorius E (2012) Hydroxyl radical-modified fibrinogen as a marker of thrombosis: the role of iron. Hematology 17(4):241-247. doi:10.1179/1607845412y.0000000004
42. Gutteridge JM, Rowley DA, Griffiths E, Halliwell B (1985) Low-molecular-weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis. Clin Sci (Lond) 68(4):463-467 (Pubitemid 15127670)
43. Moore K, Roberts LJ 2nd (1998) Measurement of lipid peroxidation. Free Radic Res 28(6):659-671 (Pubitemid 28454258)
44. Malik I, Danesh J, Whincup P et al (2001) Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis. Lancet 358(9286):971-976. doi:10.1016/s0140-6736(01)06104-9
45. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR (2002) Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347(20):1557-1565. doi:10.1056/NEJMoa021993 (Pubitemid 35315836)
46. Ridker PM, Danielson E, Fonseca FA et al (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359(21):2195-2207. doi:10.1056/NEJMoa0807646